|
|
Article: BioChemics & Beth Israel Deaconess Medical Center Announce Wound Healing Research Collaboration.
- Article from:
- Business Wire
- Article date:
- April 8, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DANVERS, Mass. -- BioChemics, Inc., a company "pioneering transdermal drug delivery," announced it has entered into a research collaboration with Beth Israel Deaconess Medical Center (BIDMC) to evaluate the wound healing effects of some of the Company's novel, proprietary formulations in preclinical models. BIDMC is one of the largest, most respected research hospitals in the country. BioChemics is a pharmaceutical company that has developed a novel, transdermal drug delivery system that for the first time may allow almost any drug to be efficiently delivered through the skin. The transdermal technology, called VALE[R] (Vaso-active Lipid Encapsulated), may allow a ...